Zoetis Inc. financial data

Symbol
ZTS on NYSE
Industry
Pharmaceutical Preparations
Location
10 Sylvan Way, Parsippany, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 345 % +11.5%
Quick Ratio 138 % +12.9%
Debt-to-equity 182 % -10.6%
Return On Equity 48 % -2.1%
Return On Assets 17 % +5.39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 451M shares -1.73%
Common Stock, Shares, Outstanding 452M shares -1.74%
Entity Public Float 79.3B USD -1.5%
Common Stock, Value, Issued 5M USD 0%
Weighted Average Number of Shares Outstanding, Basic 453M shares -1.61%
Weighted Average Number of Shares Outstanding, Diluted 454M shares -1.71%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.15B USD +9.33%
Nonoperating Income (Expense) 7M USD -94%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.05B USD +6.01%
Income Tax Expense (Benefit) 613M USD +2%
Net Income (Loss) Attributable to Parent 2.43B USD +6.58%
Earnings Per Share, Basic 5.34 USD/shares +8.54%
Earnings Per Share, Diluted 5.32 USD/shares +8.35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.71B USD -2.28%
Accounts Receivable, after Allowance for Credit Loss, Current 1.41B USD +12.3%
Inventory, Net 2.42B USD -12%
Other Assets, Current 427M USD -8.57%
Assets, Current 6.28B USD +0.96%
Deferred Income Tax Assets, Net 409M USD +115%
Property, Plant and Equipment, Net 3.3B USD +6.66%
Operating Lease, Right-of-Use Asset 223M USD -1.33%
Intangible Assets, Net (Excluding Goodwill) 1.19B USD -15.2%
Goodwill 2.74B USD -0.65%
Other Assets, Noncurrent 215M USD -0.46%
Assets 14.4B USD +1.78%
Accounts Payable, Current 404M USD +4.12%
Employee-related Liabilities, Current 335M USD +18%
Accrued Liabilities, Current 683M USD +0.15%
Liabilities, Current 1.7B USD +5.85%
Accrued Income Taxes, Noncurrent 274M USD +4.58%
Deferred Income Tax Liabilities, Net 172M USD +7.5%
Operating Lease, Liability, Noncurrent 181M USD -5.24%
Other Liabilities, Noncurrent 220M USD -15.1%
Liabilities 9.12B USD +1.01%
Accumulated Other Comprehensive Income (Loss), Net of Tax -851M USD -4.55%
Retained Earnings (Accumulated Deficit) 11.8B USD +16.4%
Stockholders' Equity Attributable to Parent 5.23B USD +3.07%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.23B USD +3.15%
Liabilities and Equity 14.4B USD +1.78%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 595M USD +8.38%
Net Cash Provided by (Used in) Financing Activities -524M USD +70.9%
Net Cash Provided by (Used in) Investing Activities -131M USD +39.4%
Common Stock, Shares Authorized 6B shares 0%
Common Stock, Shares, Issued 502M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -66M USD +95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.71B USD -2.28%
Interest Paid, Excluding Capitalized Interest, Operating Activities 68M USD -23.6%
Deferred Tax Assets, Valuation Allowance 131M USD +1.55%
Operating Lease, Liability 236M USD +3.06%
Payments to Acquire Property, Plant, and Equipment 140M USD -37.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2.39B USD +5.19%
Lessee, Operating Lease, Liability, to be Paid 271M USD -3.21%
Property, Plant and Equipment, Gross 5.8B USD +14.8%
Operating Lease, Liability, Current 48M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 48M USD +6.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 57M USD +9.62%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +36%
Deferred Income Tax Expense (Benefit) -43M USD -638%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35M USD -31.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38M USD +2.7%
Deferred Tax Assets, Operating Loss Carryforwards 133M USD +18.8%
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 217M USD +7.43%
Lessee, Operating Lease, Liability, to be Paid, Year Four 30M USD -3.23%
Operating Lease, Payments 15M USD +7.14%
Additional Paid in Capital 1.16B USD +4.21%
Amortization of Intangible Assets 172M USD -8.02%
Depreciation, Depletion and Amortization 500M USD +3.31%
Deferred Tax Assets, Net of Valuation Allowance 409M USD +115%
Share-based Payment Arrangement, Expense 18M USD +5.88%
Interest Expense 233M USD -3.72%